Heparin-induced thrombocytopenia

Blut

Volumn 58, Issue 2, 1989, Pages 53-57

  Chong, B H ^a   Berndt, M C ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b Westmead Centre   (Australia)

Author keywords

Complication; Heparin anticoagulant therapy; Thrombocytopenia

Indexed keywords

HEPARIN;

HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

HEPARIN; HUMAN; SUPPORT, NON-U.S. GOV'T; THROMBOCYTOPENIA;

EID: 0024543740     PISSN: 00065242     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/BF00320647     Document Type: Article

References (44)

1. Heparin-induced thrombocytopenia and recurrent thromboembolism
2. Heparin-induced thrombocytopenia. What is its real frequency
3. Incidence of thrombocytopenia in medical patients on ‘mini-dose’ heparin prophylaxis
4. Heparin-associated thrombocytopenia: a comparison of three heparin preparations
5. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients
6. Substitution of antithrombin III in shock and DIC: a randomized study
7. Thrombosis and thrombocytopenia induced by heparin
8. Antiplatelet heparin-dependent antibody interacts with the platelet Fcreceptor
9. Affinity isolation and characterisation of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets
10. Heparin-induced thrombocytopenia
11. Heparin-induced thrombocytopenia: further studies on the effects of heparin-dependent antibodies on platelets
12. Platelet proaggregating factor of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia
13. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IGG antibody that induces thromboxane synthesis and platelet aggregation
14. Heparin-induced thrombocytopenia: Studies with a low molecular weight heparinoid, Org 10172
15. Heparin-associated thrombocytopenia
16. The effect of commercial heparin on the platelet count
17. Pentosane polysulphate associated thrombocytopenia
18. Thrombocytopenia related to synthetic heparin analogue therapy
19. Heparin-induced thrombocytopenia
20. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid
21. Heparin flushes and thrombocytopenia (letter)
22. Persistent heparin-induced thrombocytopenia despite therapy with low-molecular-weight-heparin
23. Heparin-induced thrombocytopenia, thrombosis and haemorrhage
24. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia
25. The pathophysiology of heparin-induced thrombocytopenia
26. Heparin-associated thrombocytopenia
27. Spontaneous platelet aggregation in heparin-treated patients
28. Treatment of heparin-associated thrombobocytopenia and thrombosis with low molecular weight heparin (CY 216)
29. Heparin-associated thrombocytopenia: antibody binding specificity to platelet antigens
30. Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal muscosal origin
31. In vitro assessment of low-molecular-weight heparin in patients with thrombocytopenia induced by standard heparin
32. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease
33. Interaction of platelet membrane receptor with von Willebrand factor ristocetin, and the Fc region of imunoglobulin G
34. Heparin-induced thrombocytopenia
35. Heparin-associated thrombocytopenia
36. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia
37. Studies of the frequency of heparin-associated thrombocytopenia
38. Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications
39. Heparin-induced thrombocytopenia: variable platelet rich plasma reactivity to heparin dependent platelet aggregating factor
40. Effect of heparin and heparin fractions on platelet aggregation
41. A diagnostic test for heparin-induced thrombocytopenia
42. Antibodies interacting with, and corresponding binding site for, heparin on human thrombocytes